Human hallucinogenic drug research in the United States: a present-day case history and review of the process

Authors

Rick J. Strassman, Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque 87131

Document Type

Article

Publication Date

1-1-1991

Abstract

Legitimate human research with hallucinogenic drugs, although of great theoretical and practical interest, involves daunting regulatory hurdles that have discouraged investigators from attempting such work. Using the example of the author's own application for and receipt of federal permission to administer N,N-dimethyltryptamine (DMT) to humans, this article reviews the application process, obstacles and their solutions, and the local and federal issues involved. Further human research with hallucinogens is possible if a persistent and collaborative effort is made with the relevant institutions that oversee the performance of this type of research.

Publisher

Haight-Asbury Publications In Association With The Haight-Asbury Free Medical Clinic

Publication Title

Journal of psychoactive drugs

ISSN

0279-1072

Volume

23

Issue

1

First Page

29

Last Page

38

Recommended Citation

Strassman RJ. Human hallucinogenic drug research in the United States: a present-day case history and review of the process. J Psychoactive Drugs. 1991 Jan-Mar;23(1):29-38. doi: 10.1080/02791072.1991.10472572. PMID: 1941365.